Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis.
See All Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis.
Braun J, Kay J. The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis. Expert Opin Drug Saf. 2017 Mar; 16(3):289-302.
View in:
PubMed
subject areas
Antirheumatic Agents
Arthritis, Rheumatoid
Biosimilar Pharmaceuticals
Drug Design
Health Services Accessibility
Humans
Rituximab
Tumor Necrosis Factor-alpha
authors with profiles
Jonathan Kay MD